Science Explorer Back to mapMap
Discussion
Researcher · Chinese Academy of Medical Sciences & Peking Union Medical College · China

Jianzhong Shou

Jianzhong Shou publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment and Urinary and Genital Oncology Studies.

ORCID 0000-0002-1148-2442 OpenAlex
World rank
#4,106,997
of 7,710,434 ranked researchers
Rank in China
#636,188
of 978,568
Works
114
Citations
2.7k
Citations per work
24.0
h-index
20
i10-index 33Top 16% in Surgery
Jianzhong Shou

What does Jianzhong Shou research?

Jianzhong Shou's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (5%).

Health Sciences: 64 works · 56.3% of their workMedicine: 64 works · 56.3% of their workSurgery: 29 works · 25.2% of their workPulmonary and Respiratory Medicine: 23 works · 19.9% of their workOncology: 13 works · 11.2% of their workEverything else: 29 works · 25.3% of their workLife Sciences: 21 works · 18.4% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 13.4% of their workMolecular Biology: 12 works · 10.9% of their workGenetics: 3 works · 2.5% of their workImmunology and Microbiology: 6 works · 5.0% of their workImmunology: 6 works · 5.0% of their workTHEIR WORKJianzhong Shou114works
Life Sciences18%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6456.3%
  2. Everything else2925.3%
    1. Biochemistry, Genetics and Molecular Biology1513.4%
    2. Immunology and Microbiology65.0%
  1. 1Surgery25% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Oncology11% of their works
  4. 4Molecular Biology11% of their works
  5. 5Immunology5% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Jianzhong Shou's research?

The keywords of their largest research topics: Immunotherapy, Molecular Characterization, Genetic Mutations, Bladder Cancer, Clinical Guidelines, Urothelial Carcinoma, Metastatic and Renal Cell Carcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Immunotherapy863 topics
  2. Molecular Characterization752 topics
  3. Genetic Mutations442 topics
  4. Bladder Cancer421 topic
  5. Clinical Guidelines422 topics
  6. Urothelial Carcinoma421 topic
  7. Metastatic331 topic
  8. Renal Cell Carcinoma331 topic
  9. Primary Urethral Carcinoma241 topic
  10. Urachal Carcinoma241 topic
  11. Prostate Cancer202 topics
  12. Immune Checkpoint Blockade131 topic
  13. PD-1 and PD-L1131 topic
  14. Androgen Receptor111 topic
  15. Genomic Profiling111 topic
  16. Kidney Organoids111 topic
  17. Nephrogenesis111 topic
  18. Activation101 topic
  19. Macrophage101 topic
  20. Radiation Therapy91 topic
  21. Screening91 topic

Where does Jianzhong Shou work?

Jianzhong Shou's main affiliation in the publication record is Chinese Academy of Medical Sciences & Peking Union Medical College, China.

How many publications and citations does Jianzhong Shou have?

OpenAlex counts 114 works and 2,739 citations for Jianzhong Shou, an h-index of 20, ranking #4,106,997 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Jianzhong Shou

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jianzhong Shou. Posts are plain text and can be reported.